AXGN Q4 2024 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$49M+15.1% YoY

Gross Profit

$38M76.1% margin

Operating Income

$2M4.1% margin

Net Income

$450,0000.9% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$204M

Total Liabilities

$100M

Stockholders' Equity

$104M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$43M	+15.1%
Gross Profit	$38M	$34M	+11.3%
Operating Income	$2M	-$3M	+163.1%
Net Income	$450,000	-$4M	+111.6%